LATE DIAGNOSIS OF ANTI-MDA5 ANTIBODY-POSITIVE RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE WITH CUTANEOUS MANIFESTATIONS

被引：0

作者：

Kay, Carl

Anderson, Erika

Askin, Cyrus

Warren, Whittney

机构：

来源：

CHEST | 2020年 / 158卷 / 04期

关键词：

D O I：

10.1016/j.chest.2020.08.1461

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1624A / 1624A

页数：1

共 50 条

[31] Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody-Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk [J].

Lv, Chengyin ;

You, Hanxiao ;

Xu, Lingxiao ;

Wang, Lei ;

Yuan, Fenghong ;

Li, Ju ;

Wu, Min ;

Zhou, Shiliang ;

Da, Zhanyun ;

Qian, Jie ;

Wei, Hua ;

Yan, Wei ;

Zhou, Lei ;

Wang, Yan ;

Yin, Songlou ;

Zhou, Dongmei ;

Wu, Jian ;

Lu, Yan ;

Su, Dinglei ;

Liu, Zhichun ;

Liu, Lin ;

Ma, Longxin ;

Xu, Xiaoyan ;

Zang, Yinshan ;

Liu, Huijie ;

Ren, Tianli ;

Wang, Fang ;

Zhang, Miaojia ;

Tan, Wenfeng .

JOURNAL OF RHEUMATOLOGY, 2023, 50 (02) :219-226

[32] Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis [J].

Gono, Takahisa ;

Sato, Shinji ;

Kawaguchi, Yasushi ;

Kuwana, Masataka ;

Hanaoka, Masanori ;

Katsumata, Yasuhiro ;

Takagi, Kae ;

Baba, Sayumi ;

Okamoto, Yuko ;

Ota, Yuko ;

Yamanaka, Hisashi .

RHEUMATOLOGY, 2012, 51 (09) :1563-1570

[33] PROGRESSIVE INTERSTITIAL LUNG DISEASE ASSOCIATED WITH ANTI-MDA5 POSITIVE DERMATOMYOSITIS [J].

Vahabzadeh, Arshia ;

Ventimiglia, William A. .

CHEST, 2023, 164 (04) :3217A-3217A

[34] Progressive Interstitial Lung Disease Associated With Anti-MDA5 Positive Dermatomyositis [J].

Vahabzadeh, A. ;

Ventimiglia, W. A. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209

[35] Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review [J].

Nishi, Kentaro ;

Ogura, Masao ;

Tamai, Naotaka ;

Gima, Naofumi ;

Ide, Kentaro ;

Koinuma, Goro ;

Kamei, Koichi ;

Ito, Shuichi .

PEDIATRIC RHEUMATOLOGY, 2022, 20 (01)

[36] Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review [J].

Kentaro Nishi ;

Masao Ogura ;

Naotaka Tamai ;

Masafumi Gima ;

Kentaro Ide ;

Goro Koinuma ;

Koichi Kamei ;

Shuichi Ito .

Pediatric Rheumatology, 20

[37] Anti-MDA5 antibody-positive dermatomyositis with severe cutaneous ulcers [J].

Gul, Busra Demirbag ;

Senturk, Nilgun ;

Baycelebi, Deniz ;

Yildiz, Levent .

TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2022, 56 (04) :193-196

[38] Anti-MDA-5 antibody-positive bullous dermatomyositis with palmar papules complicating rapidly progressive interstitial lung disease [J].

Fujimoto, Noriki ;

Honda, Shinichiro ;

Wakabayashi, Makiko ;

Hamaguchi, Yasuhito ;

Fujimoto, Manabu ;

Tanaka, Toshihiro .

MODERN RHEUMATOLOGY, 2016, 26 (04) :614-616

[39] Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model [J].